Biological Systems Engineering Department, 210-A Seitz Hall, Blacksburg, VA 24061, USA.
Curr Opin Biotechnol. 2010 Oct;21(5):663-9. doi: 10.1016/j.copbio.2010.05.005. Epub 2010 Jun 19.
Cell-free synthetic pathway biotransformation (SyPaB) is the implementation of complicated biochemical reactions by in vitro assembling a number of enzymes or their complexes and coenzymes. Assembly of numerous enzymes without cellular membrane, gene regulation, or undesired pathway can circumvent some of the obstacles to modifying living microorganisms. Several synthetic pathways for the production of liquid biofuels--alcohols and hydrocarbon precursors (polyols) as well as gaseous biofuel--hydrogen have been presented. The present constraints to SyPaB include the lack of stable enzymes as Lego-like building blocks, the different optimal reaction conditions for individual enzyme, and the use of costly labile coenzymes. It is expected that high-yield SyPaB will be an important platform for producing low-cost biofuels and biochemicals.
无细胞合成途径生物转化 (SyPaB) 是通过体外组装大量酶或其复合物和辅酶来实施复杂生化反应的方法。在不使用细胞膜、基因调控或不需要的途径的情况下组装大量酶,可以避免一些修饰活微生物的障碍。已经提出了几种用于生产液体生物燃料(醇和碳氢化合物前体(多元醇)以及气态生物燃料-氢气)的合成途径。目前 SyPaB 面临的限制包括缺乏稳定的酶作为类似乐高积木的构建块、单个酶的不同最佳反应条件以及使用昂贵的不稳定辅酶。预计高产 SyPaB 将成为生产低成本生物燃料和生物化学物质的重要平台。